Literature DB >> 6300881

Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types.

R T Maguire, T S Robins, S S Thorgeirsson, C A Heilman.   

Abstract

Burkitt lymphomas contain reciprocal translocations between chromosome 8 and one of the chromosomes containing the immunoglobulin gene loci, prompting speculation that consequent activation of a crucial gene(s) on chromosome 8 might be involved in the generation of these tumors. Recently the human counterparts of the retroviral oncogenes v-myc and v-mos have been mapped to chromosome 8. We have, therefore, analyzed the level of transcription of the cellular myc and mos genes in a variety of undifferentiated B cell lymphomas of Burkitt and non-Burkitt type that possess either an 8;14 or an 8;22 translocation. These lines expressed 2- to 5-fold more myc-specific RNA than do B cell lines without a translocation. Tumor cell lines of American origin with an 8;14 or 8;22 translocation expressed similar amounts of myc-specific RNA. Tumor cell lines of African origin contained slightly higher levels of myc-specific RNA than did those of American origin. However, level of expression does not appear to correlate with the presence or absence of Epstein-Barr virus. Therefore, a major increase in the transcription of this gene secondary to translocation is unlikely to be the cause of Burkitt lymphoma. There was no evidence of mos-related transcripts in any of the cell lines tested.

Entities:  

Mesh:

Year:  1983        PMID: 6300881      PMCID: PMC393728          DOI: 10.1073/pnas.80.7.1947

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Methylmercury as a reversible denaturing agent for agarose gel electrophoresis.

Authors:  J M Bailey; N Davidson
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Primary activation of the vitellogenin gene in the rooster.

Authors:  R G Deeley; J I Gordon; A T Burns; K P Mullinix; M Binastein; R F Goldberg
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

4.  Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.

Authors:  L Zech; U Haglund; K Nilsson; G Klein
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

5.  Marker band in one chromosome 14 from Burkitt lymphomas.

Authors:  G Manolov; Y Manolova
Journal:  Nature       Date:  1972-05-05       Impact factor: 49.962

6.  A virus-induced rhabdomyosarcoma of mice.

Authors:  J B Moloney
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

7.  Chromosomal location of the genes for human immunoglobulin heavy chains.

Authors:  C M Croce; M Shander; J Martinis; L Cicurel; G G D'Ancona; T W Dolby; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Identification of procollagen mRNAs transferred to diazobenzyloxymethyl paper from formaldehyde agarose gels.

Authors:  N Rave; R Crkvenjakov; H Boedtker
Journal:  Nucleic Acids Res       Date:  1979-08-10       Impact factor: 16.971

10.  Murine sarcoma virus transformation of BALB-3T3 cells: lack of dependence on murine leukemia virus.

Authors:  S A Aaronson; J L Jainchill; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1970-08       Impact factor: 11.205

View more
  24 in total

1.  Epstein-Barr virus-transformed pro-B cells are prone to illegitimate recombination between the switch region of the mu chain gene and other chromosomes.

Authors:  E Altiok; G Klein; L Zech; M Uno; B E Henriksson; S Battat; Y Ono; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  Sequences upstream of c-mos(rat) that block RNA accumulation in mouse cells do not inhibit in vitro transcription.

Authors:  F A van der Hoorn; V Müller; L I Pizer
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

3.  Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes.

Authors:  M Stevenson; D J Volsky
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

4.  Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics.

Authors:  K Virtaneva; F A Wright; S M Tanner; B Yuan; W J Lemon; M A Caligiuri; C D Bloomfield; A de La Chapelle ; R Krahe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.

Authors:  G Pernegger; T F Schulz; M Hosp; B L Myones; A L Petzer; A Eigentler; G Böck; G Wick; M P Dierich
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

6.  Multiple growth-associated nuclear proteins immunoprecipitated by antisera raised against human c-myc peptide antigens.

Authors:  H Persson; H E Gray; F Godeau; S Braunhut; A R Bellvé
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

7.  Translational efficiency of cMyc mRNA in Burkitt lymphoma cells.

Authors:  T W Nilsen; P A Maroney
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

8.  Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations.

Authors:  D Benjamin; I T Magrath; T J Triche; R W Schroff; J P Jensen; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

Review 9.  Onc genes and other new targets for cancer chemotherapy.

Authors:  H Busch
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 10.  An appraisal of the application of recombinant DNA techniques to chromosome defects.

Authors:  K P Ellis; K E Davies
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.